Revolution Medicines is a late-stage clinical oncology company focused on developing novel targeted therapies for patients with RAS-addicted cancers. Their R&D pipeline includes several RAS(ON) inhibitors currently in clinical development. This position involves joining the Revolution Medicines team to contribute to the commitment to patients with cancers harboring mutations in the RAS signaling pathway. The role serves as a study level statistician for oncology studies, coordinating activities with other functional groups to ensure timely deliverables.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director